A novel approach to target inflammatory diseases A novel approach to target inflammatory diseases Inotrem is an advanced clinical stage biotechnology company specialized in immunotherapy. The company has developed a new concept of immunomodulation that targets TREM-1, to control unbalanced and dysregulated inflammatory responses. More about Inotrem Inotrem targets the TREM-1 pathway as a key
Total raised: $160.81M
Founded date: 2013
Investors 2
| Date | Name | Website |
| - | Incubateur... | incubateur... |
| - | Andera Par... | anderapart... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 12.07.2021 | - | $53.34M | - |
| 12.02.2020 | Series B | $63.33M | - |
| 12.09.2019 | Series B | $44.14M | - |
Mentions in press and media 16
| Date | Title | Description | Source |
| 08.01.2024 | Inotrem Successfully Reaches Agreement with the FDA for a ... | Novel biomarker-guided Phase 3 registration trial in septic shock with an enrichment strategy-based ... | fh-partner... |
| 25.10.2022 | Inotrem Announces That Its ESSENTIAL Phase II Study for th... | Inotrem, an advanced clinical stage biotech company specializing in immunotherapies for acute and ... | fh-partner... |
| 13.10.2022 | Inotrem announces the outcome of its Phase II ASTONISH tri... | Inotrem, an advanced clinical stage biotech company specializing in immunotherapies for acute and ... | fh-partner... |
| 31.05.2022 | Inotrem announce the appointment of Luke Beshar as Chairma... | Inotrem, an advanced clinical stage biotech company developing TREM- 1 targeting immunotherapies for... | fh-partner... |
| 14.04.2022 | Inotrem and the Crohn’s & Colitis Foundation Sign a R&... | Inotrem, an advanced clinical stage biotech company specialized in immunotherapies for acute and c... | fh-partner... |
| 24.03.2022 | Celsius aims to cool down inflammation with new investo... | Broad Institute spinout Celsius Therapeutics is turning up the heat on the financing front... | endpts.com... |
| 09.11.2021 | Inotrem appoints Dr. Gregory Meiffren as Project Director ... | Inotrem, an advanced clinical stage biotech company specialized in immunotherapies targeting the TRE... | fh-partner... |
| 12.07.2021 | Inotrem Receives Approval to Expand Nangibotide Clinical T... | Inotrem S.A., a biotechnology company specializing in the development of immunotherapies targeting... | fh-partner... |
| 23.06.2021 | Inotrem adds a new strategic asset to its immunotherapy an... | Inotrem, an advanced clinical stage biotech company specialized in immunotherapies for acute and c... | fh-partner... |
| 10.06.2021 | Inotrem announces positive outcome of interim futility ana... | Inotrem, an advanced clinical stage biotech company specialized in immunotherapies for acute and c... | fh-partner... |
Show more